Skip to content
SentinelMarket desk
Switch to dark mode

와이바이오로직스

338840KOSDAQView the 바이오 R&D sectorTheme Bio & healthcare

8,130KRWMarket close of 10/20 (Tue)

Up +6.27%+480KRWMarket close of 10/20 (Tue)

Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)8,820KRWUp +8.49%

Preliminary · just after the close · replaced by official KRX data tomorrow morning

Open
7,750
High
8,300
Low
7,510
Day range
Day range low 7,510 high 8,300, open 7,750, close 8,130, previous close 7,650
Volume
4×10K shares
327.36 million KRW 1.55× the 20-session average

Market close of 10/20 (Tue)

Where it sits in the 1-year range

1-year close range 6,700 to 35,600 won, 5% up from the low

5% of the way up from the lowest close in 1 year (252 sessions) · -77.2% from the high

Something to check

1 to check: bigger daily move than usual

Free · no sign-inSource from 2021-05-17

Points to check

  • Daily moveto check+6.27%+6.27%, 2.1× the usual (20-session average ±3.04%)
    That day +6.27% · usual ±3.04% · large-move threshold ±6.1%
  • Earningsnot verifiedOutside financial data coverage, so not verified
  • Recent filingsnot verifiedOutside filing data coverage, so not verified

The other 3

  • Foreign & institutionalnot verified
  • Trading value1.5×usual range
  • Data date10/20 (Tue)Market close
See the full check report

Same sector · 바이오 R&D

Down -2.19%

· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW

Same sector · top by trading value
Stock20DChangeTrading value
알테오젠Close over the last 20 sessions -9.6%Down -3.35%51.1B KRW
올릭스Close over the last 20 sessions -12.2%Down -4.03%19.1B KRW
디앤디파마텍Close over the last 20 sessions -11.8%Down -1.93%15.1B KRW
리가켐바이오Close over the last 20 sessions -15.4%Down -1.41%12.1B KRW
프로티나Close over the last 20 sessions +31.8%Up +7.38%10.0B KRW

Schedule

  • Next data 10/22 (Thu) after 08:50

Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 81% of trading value, about 92% of market capitalisation. Coverage status →

For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.